A literature review of enzyme kinetic parameters for CYP3A4-mediated metabolic reactions of 113 drugs in human liver microsomes: Structure-kinetics relationship assessment

被引:71
作者
Bu, HZ [1 ]
机构
[1] PGRD, Dept Pharmacokinet Dynam & Metab, San Diego, CA 92121 USA
关键词
P450; CYP3A4; human liver microsomes; lipophilicity; kinetics;
D O I
10.2174/138920006776359329
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytochrome P450 (CYP) enzymes represent a superfamily of hemoproteins that are involved in the metabolism of a wide variety of endogenous and exogenous compounds. For a given CYP enzyme, kinetic properties of a substrate are usually related to substrate lipophilicity (log P or log D-7.4). In this review, enzyme kinetic parameters (K-m, V-max, and V-max/K-m) of 215 CYP3A4-mediated metabolic reactions of 113 drugs in human liver microsomes were obtained from the literature, and lipophilicity values of the 113 drugs were calculated using the ACD/Labs 8.0 program. A low degree of K-m- or (V-max/K-m)-lipophilicity correlation, but no V-max-lipophilicity correlation, is exhibited for the CYP3A4-mediated reactions. Overall, K-m, decreases, but V-max/K-m increases, with increasing substrate lipophilicity, and V-max appears to be independent of substrate lipophilicity. In other words, a low K. generally confers a high V-max/K-m ratio for a substrate. The degree of lipophilicity-kinetics correlations is related to both reaction types (or reaction mechanisms) and regiochemical positions (or physicochemical properties) of the reaction groups of the substrates. Among the categorized CYP3A4-mediated reactions, the best lipophilicity-kinetics correlation is achieved for carbon hydroxylation, followed by N-dealkylation. No or little lipophilicity-kinetics correlations are seen for N, S-oxidation and other reactions. Within the hydroxylation group, aliphatic hydroxylation shows the best lipophilicity-kinetics correlation while hydroxylation on a carbon atom adjacent to an aromatic ring does not show any lipophilicity-kinetics correlation. The detailed structural and kinetic data sets of the human liver microsomal CYP3A4-mediated reactions represent a specialized database useful for researchers working in the area of structure-metabolism relationship modeling and analysis.
引用
收藏
页码:231 / 249
页数:19
相关论文
共 152 条
[1]   In vitro metabolism and interaction of cilostazol with human hepatic cytochrome P450 isoforms [J].
Abbas, R ;
Chow, CP ;
Browder, NJ ;
Thacker, D ;
Bramer, SL ;
Fu, CJ ;
Forbes, W ;
Odomi, M ;
Flockhart, DA .
HUMAN & EXPERIMENTAL TOXICOLOGY, 2000, 19 (03) :178-184
[2]   CORTISOL METABOLISM IN-VITRO .3. INHIBITION OF MICROSOMAL 6-BETA-HYDROXYLASE AND CYTOSOLIC 4-ENE-REDUCTASE [J].
ABEL, SM ;
BACK, DJ .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1993, 46 (06) :827-832
[3]   IDENTIFICATION OF HUMAN LIVER CYTOCHROME-P450 ISOFORMS MEDIATING OMEPRAZOLE METABOLISM [J].
ANDERSSON, T ;
MINERS, JO ;
VERONESE, ME ;
TASSANEEYAKUL, W ;
TASSANEEYAKUL, W ;
MEYER, UA ;
BIRKETT, DJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 36 (06) :521-530
[4]   Comparative study of the metabolism of drug substrates by human cytochrome P450 3A4 expressed in bacterial, yeast and human lymphoblastoid cells [J].
Andrews, J ;
Abd-Ellah, MF ;
Randolph, NL ;
Kenworthy, KE ;
Carlile, DJ ;
Friedberg, T ;
Houstont, JB .
XENOBIOTICA, 2002, 32 (11) :937-947
[5]   6α-hydroxylation of taurochenodeoxycholic acid and lithocholic acid by CYP3A4 in human liver microsomes [J].
Araya, Z ;
Wikvall, K .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 1999, 1438 (01) :47-54
[6]   The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties [J].
Austin, RP ;
Barton, P ;
Cockroft, SL ;
Wenlock, MC ;
Riley, RJ .
DRUG METABOLISM AND DISPOSITION, 2002, 30 (12) :1497-1503
[7]  
BAARNHIELM C, 1986, ACTA PHARMACOL TOX, V59, P113
[8]  
Becquemont L, 1999, DRUG METAB DISPOS, V27, P1068
[9]   INVOLVEMENT OF CYTOCHROME-P450 3A ENZYME FAMILY IN THE MAJOR METABOLIC PATHWAYS OF TOREMIFENE IN HUMAN LIVER-MICROSOMES [J].
BERTHOU, F ;
DREANO, Y ;
BELLOC, C ;
KANGAS, L ;
GAUTIER, JC ;
BEAUNE, P .
BIOCHEMICAL PHARMACOLOGY, 1994, 47 (10) :1883-1895
[10]   Metabolism of (S)-5,6-difluoro-4-cyclopropylethynyl-4-trifluoromethyl-3, 4-dihydro-2(1H)-quinazolinone, a non-nucleoside reverse transcriptase inhibitor, in human liver microsomes.: Metabolic activation and enzyme kinetics [J].
Chen, H ;
Chen, WQ ;
Gan, LS ;
Mutlib, AE .
DRUG METABOLISM AND DISPOSITION, 2003, 31 (01) :122-132